The Access Digest
The Access Digest June Issue
Diabetes Medications - 3 meters
In This Issue
Kaz Softheat   
king size deluxe heating pad
Diabetes News
the access diagest

Click below to view past issues.
Jan - Dec
- Nov - Oct
Exercise Links
Encore DeluxeRX
  • Both manual and battery pump;
  • Safest form of impotence treatment;
  • Easy to use ring ejection system;
  • 7 different sizes of rings;
  • Toll free help line available;
  • Free educational video and instructional manual
encore deluxe rx
Newsletter Highlights

Welcome to the June 2007 edition of Access Digest. Have you read any newspaper articles or seen any TV stories about diabetes drugs and medications? Of course you have, and you know how hard it is to keep up with advances in medicine. We agree, so we've taken the time to see what's new for people with diabetes. As always, talk to your doctor about any drugs that you think might benefit you.

Our Lifestyle Tip for June is about Mastering Diabetes and our Recipe of the Month is Teriyaki Tofu Kabobs. 

As always, when you see "Read More" at the end of an article, or something that is underlined, you can click on it to be linked to another Web site where you'll find more information. When you find a site that you may want to visit again in the future, you can bookmark it.

Each month we receive questions from our readers. We post some of the more frequent questions and answers for everyone to read. If you have questions or comments of your own, please e-mail them to us at the end of this issue.

We hope you enjoy this issue of our newsletter. Thank you for choosing Access Diabetic Supply as your choice for diabetic supplies.

More Heart Attacks With Avandia

Study Shows 43% More Heart Attacks With Avandia; Drugmaker Disagrees

The diabetes drug Avandia may increase a person's risk of heart attack and death due to heart disease, a new study warns. But Avandia maker GlaxoSmithKline says the study is flawed and that better data -- some already submitted to the FDA, some from an ongoing clinical trial -- show Avandia poses no significant risk to patients' heart health.

The FDA says that based on this "contradictory evidence about the risks in patients treated with Avandia," patients taking the drug -- especially those who have had heart attacks or who have underlying heart disease -- should talk with their doctors about whether to continue taking the drug. The new warning comes from an analysis of publicly-available, short-term clinical studies comparing Avandia to other diabetes treatments. It shows that Avandia increases heart attack risk by 43% -- and increases risk of death from heart disease by 64%.

However, the overall risk was small. Among the 15,560 Avandia patients there were 86 heart attacks and 39 deaths, compared with 72 heart attacks and 22 deaths among the 12,283 patients not taking Avandia.

Read More

FDA OKs New Drug for Type 2 Diabetes

The FDA has approved Janumet, a new drug for people with type 2 diabetes. Janumet is approved for use in addition to diet and exercise for patients with type 2 diabetes whose blood sugar is not adequately controlled by the diabetes drugs metformin or Januvia. Janumet is taken orally twice daily with meals. It's the first and only tablet that combines Januvia and metformin, notes Merck, the drug company that makes Janumet and Januvia.

According to a Merck news release, the FDA approved Janumet based on clinical data including Januvia and metformin as separate tablets. Another study shows that Janumet is equivalent to Januvia and metformin taken together, notes Merck. Merck says it compared Janumet to metformin in a six-month study of 701 people whose blood sugar was mildly to moderately elevated, despite taking metformin.

Read More

New Diabetes Drugs To Watch 
Diabetes afflicts 17 million Americans. Bad diets and a lack of exercise are expected to almost double the prevalence of the disease by 2015, and drug companies are pushing potential treatments to market. 

Many new drugs are in development. The competition to develop drugs that target more than one of the cellular signals called peroxisome proliferation activation receptors (PPARS) is one of the most heated in the drug industry. Such medicines could control both cholesterol and blood sugar. Unfortunately, two recent attempts faltered after causing cancer in laboratory animals. Eli Lilly and GlaxoSmithKline are working on similar drugs, but trail the separate efforts of Bristol and AstraZeneca.

Read More
New Type 2 Diabetes Drug Triggers Insulin Production 
When diet and exercise aren't enough to control type 2 diabetes, patients can try certain oral drugs to lower their blood glucose. Often though, patients who take diabetes drugs are aren't able to lower their blood glucose to a healthy level, even if they take more than one type of drug. Some patients aren't able to get their blood glucose to a healthy level by taking oral drugs to treat type 2 diabetes. So researchers wanted to see if adding another drug, Exenatide, would help them. Exenatide triggers insulin production after a meal, but only when blood glucose is high. Like insulin, it has to be injected.

One study looked at 733 adults with type 2 diabetes who were taking both metformin and a sulfonylurea to treat high blood glucose, while another study looked at 272 patients who were taking only metformin. Metformin and sulfonylureas are two of the most common types of diabetes drugs. Sulfonylureas spur the pancreas to produce more insulin, while metformin lowers the amount of glucose produced by the liver.

Read More
Healthy Living: Lifestyle Tip & Recipe of the Month 

June Lifestyle Tip: Mastering Diabetes Through Lifestyle Change

If you're like most people with diabetes, you know that exercising, eating right and managing your stress will help you manage your diabetes. During your last check-up, your doctor probably mentioned those things to you, again.

We’ve found that knowing what to do isn’t the problem for people with diabetes – it’s figuring out how to put it all together -- and maintain your daily life.

This healthy lifestyle “how-to” program has been helping people for 35 years, thanks to the diabetes expertise of leaders from the renowned Joslin Diabetes Center at the Harvard Medical School. 

  Read More

March Recipe: Teriyaki Tofu Kabobs 

This month our featured recipe is an Asian-inspired, grilled treat of tofu, peppers and pineapple.

Ingredients: Teriyaki Tofu Kabobs 

Ingredient Measure
Bamboo skewers Eight (8)
Extra firm tofu, drained and cut 3/4 pound (32 cubes)
Red pepper  One (1), cut into 16 squares
Canned pineapple chunks, (reserve 1/2 cup juice) One (1) cup 
Lite soy sauce One (1) tablespoon (Tbsp)
1 clove garlic, minced One (1)
Minced ginger Two (2) teaspoons (tsp) 
Preparation  
Soak skewers in water for 30 minutes to keep them from burning as you cook the skewers.

Meanwhile, put the tofu, red pepper, and pineapple chunks in a plastic bag or container with a lid. Add reserved pineapple juice, soy sauce, garlic, and ginger. Marinate for at least 30 minutes.

Drain, reserving marinade to baste. Thread the tofu, red pepper, and pineapple on the skewers.

Prepare an outdoor grill or oven broiler with the rack set 6 inches from the heat source. Grill or broil the kabobs about 5 minutes per side, basting with the marinade. Serve with brown rice.
Nutritional Information - Teriyaki Tofu Kabobs
Recipe makes four servings; amount per serving (2 kabobs): 
Calories:  107
Protein:  7 g
Sodium:  147 mg
Cholesterol:  0 mg
Fat:  2 g
Carbohydrates:  17 g
Exchanges:  1 Carbohydrate, 1 Very Lean Meat
Questions & Answers - Ask the Experts
Each month our staff answers questions and asks for your feedback. However, if you have urgent questions about your order or your meter, we encourage you to call our customer care department at 1-800-276-5712. We do our best to answer all questions, but we also encourage you to consult your physician.

Below are a few of the typical questions our customer care department has answered on this month's theme. Each question is linked to a Web site that gives an answer and provides more detail. We hope you find this section helpful.

Access Diabetic Supply
We are one of the nation's leading providers of diabetic supplies for people with Medicare or Private Insurance. We provide a comprehensive range of products from all major manufacturers including; blood glucose monitors, test strips, lancets and lancing devices and much more.

Please contact us with any comments or questions you may have.

Phone: 1-800-276-5712
Email: customerservice@diabeticsupply.com
Web: http://www.diabeticsupply.com

Home | About | Privacy Policy | Products | Medicare Patients | Sign Up | Contact Us | Insulin | Medicare Part B | Digest
Access Diabetic Supply logo   © 2005 Access Diabetic Supply. All Rights Reserved